FGROX | VEXPX | FGROX / VEXPX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 16 years | 57 years | - |
Gain YTD | -2.173 | -0.661 | 329% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 3000 | 33,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 917M | 22.9B | 4% |
Annual Yield % from dividends | 0.00 | 0.48 | - |
Returns for 1 year | 1.74 | 0.58 | 299% |
Returns for 3 years | -1.63 | 3.23 | -51% |
Returns for 5 years | -11.87 | 6.78 | -175% |
Returns for 10 years | 24.55 | 17.94 | 137% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MLN | 17.83 | 0.06 | +0.37% |
VanEck Long Muni ETF | |||
IBDR | 24.16 | 0.03 | +0.12% |
iShares iBonds Dec 2026 Term Corp ETF | |||
STXD | 33.66 | -0.36 | -1.06% |
Strive 1000 Dividend Growth ETF | |||
BBC | 21.75 | -0.40 | -1.80% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
FYT | 53.20 | -1.11 | -2.04% |
First Trust Small Cap Val AlphaDEX® ETF |